Evaluating ActiGraft for treating cutaneous wounds
Official title: An Observational Clinical Registry to Collect Safety and Efficacy Data on Wound Care in Medical Centers
Run by RedDress Ltd. · NCT04699305 · Data updated 2026-11-12
This study is testing if ActiGraft can help heal different types of wounds, like diabetic foot ulcers and pressure sores, in real-life situations.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | RedDress Ltd. Industry-sponsored |
| Locations | 1 site (Las Vegas, Nevada) |
| Status | Recruiting |
| Started | February 14, 2019 |
| Main results expected | July 1, 2026 |
| Study ends | January 31, 2027 |
| Registry record updated | July 29, 2025 |
| Trial ID | NCT04699305 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with exuding cutaneous wounds who can provide consent for data usage.
✕Probably not a fit
Patients who cannot read or understand English or Spanish may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter observational study aims to assess the safety and efficacy of ActiGraft in treating exuding cutaneous wounds in real-world settings. Participants will be monitored for their wound healing progress while receiving ActiGraft treatment. The study will collect health data and photographs of the wounds to analyze the outcomes effectively. The focus is on various types of wounds, including diabetic foot ulcers, pressure ulcers, surgical wounds, and trauma-related injuries.
Why it matters
Potential benefit: If successful, this treatment could significantly improve healing outcomes for patients with chronic and exuding wounds.
How similar studies have gone: While this approach is being evaluated in a real-world context, similar studies have shown promise in wound care treatments.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject is ≥18 years of age * Subject has an exuding cutaneous wound * Subject agrees to the use of his health data, including photos of his wound in analysis and publications * Subject/LAR must be able to read and understand English and/or Spanish Exclusion Criteria: * Subject/LAR is unable to read and understand English or Spanish.
Where it's running
-
Wound Care Experts
Las Vegas, Nevada, United States Recruiting
Study contacts
- Study coordinator: Sharon Sirota
- Email: sharon@reddress.co.il
- Phone: +972545800765
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating RD2 Ver.02 for managing anal fistulas
This study is testing a new treatment called RD2 Ver.02 to see if it can help people with certain types of anal fistulas heal better than a saline solution.
-
Evaluating ActiGraft for healing abdominal surgical wounds
This study is testing if a new treatment called ActiGraft can help women heal better from abdominal surgical wounds.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.